SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Thorne HealthTech, Inc. (THRN) trades at a trailing P/E of 34.0. Trailing earnings yield is 2.94%.
Criteria proven by this page:
- VALUE (23/100, Fail) — analyst consensus target implies downside from the current price ($5.75, 43.6%).
- Trailing Earnings Yield 2.94% — below bond yields — investors are paying a premium for expected growth rather than current earnings.
- Analyst consensus target $5.75 (-43.6% downside) — analysts see meaningful downside risk at the current price level.
Overall SharesGrow Score: 60/100 with 2/7 criteria passed.
SharesGrow 7-Criteria Score
✗
VALUE
23/100
Price-to-Earnings & upside
Proven by this page
✓
HEALTH
100/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — THRN
Valuation Multiples
P/E (TTM)34.0
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio2.35
EV/EBITDA0.0
Per Share Data
EPS (TTM)$0.30
Book Value / Share$0.00
Revenue / Share$4.34
FCF / Share$0.00
Yields & Fair Value
Earnings Yield2.94%
Dividend Yield0.00%
Analyst Target$5.75 (-43.6%)
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2019 |
$-0.46 |
$102.53M |
$-16.59M |
-16.2% |
| 2020 |
$-0.05 |
$138.45M |
$-2.44M |
-1.8% |
| 2021 |
$0.33 |
$185.25M |
$10.51M |
5.7% |
| 2022 |
$0.30 |
$228.73M |
$15.67M |
6.9% |
